Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ciba Vision licenses novel antiglaucoma agent from Ueno

Oct. 25, 1996

Revolutionary treatment for nearsightedness enters pivotal trials

Oct. 18, 1996

Sugen-Allergen collaboration in ophthalmic diseases

Oct. 18, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

Xalatan Solution now available for glaucoma

Sep. 20, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...